Ann: Half Year Accounts and Chairman Letter, page-6

In my view, the company issues regular presentations and news releases etc., that are clear and unambiguous. So it most likely be a rare event for Noxopharm holders on this forum to seek clarification with regard to company news releases from one another.

If there was confusion, contributors might feel compelled to make comments like 'read between the lines' or 'join the dots.' This regularly appears to be the case elsewhere - rarely here by comparison.

Furthermore, we don't appear to be a needy bunch. Yet, how often do we read contributors elsewhere, who seem to reach out ad nauseam to their CEO's - only then to post take a self-appointed role to reassure otherwise nervous investors. Again, not really required on this forum.

Finally, it would be a very rare event indeed for holders on this forum (unlike elsewhere), to refer to their CEO by first name. It is firstly disrespectful. Secondly, we don't seem to have the desire to turn contributions into a competition to prove who is best buddies with the management. There is just no need for ego-driven posts from long standing and genuine Noxopharm holders.

Regardless, I can't speak for all, but I am comfortable with my investment.

If others are, then perhaps that is the simplest and most likely explanation.